查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423672

2030 年神經刺激設備市場預測：按產品、設備類型、疾病狀況、應用、最終用戶和地區進行的全球分析

Neurostimulation Devices Market Forecasts to 2030 - Global Analysis By Product (Closed-Loop Stimulation Systems, Deep Brain Stimulation and Other Products), By Device Type, Disease Pathology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

2023年全球神經刺激設備市場價值為78.8億美元，預計2030年將達到188.9億美元，預測期內複合年成長率為13.3%。神經刺激設備是一種專門的儀器，旨在透過電或化學手段調節神經系統的活動。這些設備旨在針對特定神經或大腦區域，並透過電或化學手段調節神經活動。這些設備透過提供受控刺激來幫助緩解症狀並改善患者的生活品質，從而治療慢性疼痛、運動障礙、癲癇和憂鬱症神經系統疾病。

根據癲癇中心發布的消息，目前癲癇患者總數約5000萬，每年新增癲癇病例約240萬例。

慢性病增加

慢性疼痛症候群等慢性疾病和帕金森氏症、癲癇和抗治療性憂鬱症等神經系統憂鬱症的盛行率不斷上升，是神經刺激設備市場的關鍵促進因素。神經刺激設備提供了一種創新方法並有效緩解症狀。全球受這些慢性病影響的人數不斷增加，對先進非藥物療法的需求不斷增加，推動了神經刺激設備作為可行治療解決方案的成長和採用。

設備成本高且保險範圍有限

這些先進設備通常需要大量初始投資，限制了患者的使用並造成了財務障礙。此外，某些地區的保險覆蓋範圍和報銷政策不佳限制了患者的負擔能力和醫療保健提供者的招募。由於患者數量減少、醫療設施投資減少以及神經刺激設備普及速度放緩，這種情況將影響市場成長。

個人化治療方案的進步

創新技術和精準醫療方法可以根據患者的個別需求客製化治療方法，從而實現更有針對性的干涉措施。個人化治療考慮了患者的解剖結構、神經反應和症狀嚴重程度等因素，可以提高療效，同時減少副作用。這一趨勢不僅改善了患者的治療效果和滿意度，還促進了可自訂神經刺激設備的市場開拓，滿足多樣化的患者需求，拓寬了市場的潛在基礎，促進了成長。

主要企業之間競爭激烈

主要企業之間的激烈競爭可能會帶來潛在的市場飽和和定價壓力。隨著多家公司爭奪市場佔有率，創新至關重要，現有技術可能會更快過時。此外，為獲得競爭優勢而採取的積極定價策略可能會影響盈利並阻礙研發投資。這種競爭性的市場環境還會增加行銷成本、阻礙中小企業進入、增強市場力量並抑制創新。

COVID-19 的影響：

COVID-19 大流行導致選擇性手術（包括設備植入手術）的延誤，擾亂了神經刺激設備市場。由於醫院容量下降，醫療保健資源被用於應對流感大流行，治療被推遲，設備普及速度減慢。供應鏈中斷和物流挑戰進一步影響了製造和分銷，影響了神經刺激設備的可用性，從而影響了大流行期間的市場成長。

神經血栓切除術設備領域預計將在預測期內成為最大的領域

由於中風和血栓性疾病的增加，神經血栓切除設備領域預計將主導市場。血栓回收系統、抽吸裝置和勒除器的技術進步為清除腦動脈中的血塊提供了微創解決方案，這對於治療急性缺血性腦中風至關重要。隨著人們越來越認知到神經血栓切除術在改善患者預後方面的有效性，再加上有利的報銷政策，該細分市場正在解決中風管理中未滿足的需求，並將自己定位為神經刺激設備市場的關鍵參與者。它已經確立了自己的地位，並預計將成長顯著。

預計憂鬱症產業在預測期內複合年成長率最高

由於意識的提高、患者群體的擴大以及對抗藥性憂鬱症替代療法的需求，憂鬱症領域預計將出現最高的市場成長率。神經調節技術的不斷進步，例如深部腦部刺激（DBS）和經顱磁刺激（TMS），在緩解憂鬱症狀方面取得了可喜的成果。隨著人們對心理健康的興趣日益濃厚以及對非藥物干預措施的偏好，憂鬱症領域預計將在預測期內快速普及並實現顯著的市場成長。

比最大的地區

由於其強大的醫療基礎設施、高額研發投資以及較早採用創新技術，北美預計將獲得最大的市場佔有率。該地區是知名市場參與者的所在地，並享有優惠的報銷政策，支持神經刺激療法的普及。此外，神經系統疾病的盛行率不斷上升，加上積極努力解決慢性疾病，使北美處於神經刺激設備產業的前沿，推動了市場的顯著成長和主導地位。

複合年成長率最高的地區：

由於醫療保健支出增加、研發活動擴大以及易患神經病變的老年人口增加，歐洲將在神經刺激設備市場經歷最高的複合年成長率。有利的報銷政策和積極採用創新醫療技術的方法進一步促進了這一成長。此外，醫療保健專業人員和患者對神經刺激設備益處的認知不斷提高，正在推動該地區的市場擴張。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經刺激設備市場：依產品

  • 封閉回路型刺激系統
  • 深部腦部刺激（DBS）
  • 運動皮質刺激 (MCS)
  • 薦椎神經刺激(SNS)
  • 脊髓刺激 (SCS)
  • 三叉神經刺激（TNS）
  • 迷走神經刺激 (VNS)
  • 其他產品

第6章全球神經刺激設備市場：依設備類型

  • 動脈瘤彈簧圈栓塞裝置
    • 栓塞圈
      • 裸露的可拆卸線圈
      • 塗層可拆線圈
    • 導流裝置
    • 液態栓塞劑
  • 腦球囊血管成形術和支架系統
    • 球囊導管
    • 頸動脈支架
  • 神經血栓切除裝置
    • 血栓採集
    • 抽吸及抽吸裝置
    • 勒除器
  • 其他設備類型

第7章全球神經刺激設備市場：依疾病狀況

  • 動靜脈畸形和瘻管
  • 頸動脈狹窄
  • 腦動脈瘤
  • 缺血性中風
  • 其他疾病

第8章全球神經刺激設備市場：依應用分類

  • 憂鬱症
  • 肌張力不全症
  • 癲癇
  • 胃輕癱
  • 疼痛管理
  • 帕金森氏症
  • 發抖
  • 尿失禁和大便失禁
  • 其他用途

第9章全球神經刺激設備市場：依最終用戶分類

  • 醫院
  • 失智症護理中心
  • 專科診所
  • 調查機構
  • 其他最終用戶

第10章全球神經刺激設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Abbott Laboratories
  • Axonics Modulation Technologies
  • BioControl Medical
  • Boston Scientific Corporation
  • LivaNova
  • Mainstay Medical
  • Medtronic
  • Merck & Co., Inc
  • MicroTransponder
  • Neuronetics
  • NeuroPace
  • Nevro Corp
  • Nexeon MedSystems
  • Saluda Medical
  • Soterix Medical
  • SPR Therapeutics
  • Stimwave Technologies
  • Synapse Biomedical
  • Zynex Medical
Product Code: SMRC24906

According to Stratistics MRC, the Global Neurostimulation Devices Market is accounted for $7.88 billion in 2023 and is expected to reach $18.89 billion by 2030 growing at a CAGR of 13.3% during the forecast period. Neurostimulation devices are specialised instruments designed to modulate the nervous system's activity through electrical or chemical means. Implanted or applied externally, these devices target specific nerves or brain regions, managing neurological conditions like chronic pain, movement disorders, epilepsy, or depression by delivering controlled stimulation, aiding in symptom alleviation and enhancing the patient's quality of life.

According to the information distributed by the Epilepsy Center, by and by, around 50 million patients are living with epilepsy overall and around 2.4 million new cases are analyzed yearly.

Market Dynamics:

Driver:

Increasing prevalence of chronic disorders

The rising prevalence of chronic disorders, such as chronic pain syndromes and neurological conditions like Parkinson's disease, epilepsy and treatment-resistant depression, acts as a significant driver in the neurostimulation device market. Neurostimulation devices offer an innovative approach, providing effective symptom relief. With an increasing population affected by these chronic ailments globally, there's heightened demand for advanced, non-pharmacological treatments, propelling the growth and adoption of neurostimulation devices as viable therapeutic solutions.

Restraint:

High device costs and limited insurance coverage

The substantial initial investment required for these advanced devices often limits patient access, creating financial barriers. Additionally, inadequate insurance coverage or reimbursement policies in certain regions restrict patient affordability and healthcare provider adoption. This situation impacts market growth by reducing patient pool sizes and healthcare facility investments, slowing down the adoption rate of neurostimulation devices.

Opportunity:

Advancements in personalized treatment options

Tailoring therapies to individual patient needs through innovative technologies and precision medicine approaches allows for more targeted interventions. Personalised treatments, considering factors like patient anatomy, neural responses and condition severity, enhance efficacy while reducing adverse effects. This trend not only improves patient outcomes and satisfaction but also drives market growth by fostering the development of customisable neurostimulation devices, meeting the diverse needs of patients and expanding the market's potential reach.

Threat:

Intense competition among key players

Intense competition among key players poses a threat due to potential market saturation and pricing pressures. With multiple companies vying for market share, innovation becomes critical, potentially leading to the faster obsolescence of existing technologies. Moreover, aggressive pricing strategies to gain a competitive edge might impact profitability and hinder investment in research and development. This competition-driven environment may also elevate marketing costs and hinder smaller players' entry, consolidating market dominance and potentially stifling innovation.

Covid-19 Impact:

The COVID-19 pandemic disrupted the neurostimulation devices market by causing delays in elective surgeries, including device implantation procedures. Reduced hospital capacities and diverted healthcare resources towards managing the pandemic led to deferred treatments and slowed device adoption. Supply chain disruptions and logistical challenges further affected manufacturing and distribution, impacting the accessibility of neurostimulation devices and consequently affecting market growth during the pandemic period.

The neurothrombectomy devices segment is expected to be the largest during the forecast period

The neurothrombectomy devices segment is poised to dominate the market due to rising incidences of stroke and thrombotic conditions. Technological advancements in clot retrieval systems, suction devices and snares offer minimally invasive solutions for removing clots from cerebral arteries, vital in treating acute ischemic strokes. As awareness grows regarding the effectiveness of neurothrombectomy in improving patient outcomes, coupled with favorable reimbursement policies, this segment anticipates substantial growth, addressing an unmet need in stroke management and positioning itself as a pivotal player in the neurostimulation devices market.

The depression segment is expected to have the highest CAGR during the forecast period

The depression segment is projected to experience the highest growth rate in market due to increasing awareness, expanding patient populations and the demand for alternative treatments for medication-resistant depression. Continuous advancements in neuromodulation technologies, such as deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), offer promising outcomes in alleviating depressive symptoms. With a growing emphasis on mental health and a preference for non-pharmacological interventions, the depression segment is anticipated to witness rapid adoption and substantial market growth during the forecast period.

Region with largest share:

North America is set to secure the largest market share, due to its robust healthcare infrastructure, high investment in research and development and early adoption of innovative technologies. The region hosts prominent market players and enjoys favourable reimbursement policies, encouraging widespread adoption of neurostimulation therapies. Additionally, the increased prevalence of neurological disorders, coupled with a proactive approach towards addressing chronic conditions, positions North America at the forefront, driving substantial market growth and dominance in the neurostimulation devices industry.

Region with highest CAGR:

Europe is set to experience the highest CAGR in the neurostimulation devices market, owing to the increased healthcare expenditure, expanding R&D activities, and a growing geriatric population susceptible to neurological disorders. Favourable reimbursement policies and a proactive approach to adopting innovative medical technologies further contribute to this growth. Additionally, rising awareness among both healthcare providers and patients about the benefits of neurostimulation devices propels market expansion in the region.

Key players in the market

Some of the key players in Neurostimulation Devices Market include Abbott Laboratories, Axonics Modulation Technologies, BioControl Medical, Boston Scientific Corporation, LivaNova, Mainstay Medical, Medtronic, Merck & Co., Inc, MicroTransponder, Neuronetics, NeuroPace, Nevro Corp, Nexeon MedSystems, Saluda Medical, Soterix Medical, SPR Therapeutics, Stimwave Technologies, Synapse Biomedical and Zynex Medical.

Key Developments:

In May 2023, Abbott received FDA approval for its spinal cord stimulation (SCS) systems for treating chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain. This new indication applies to all Abbott's SCS products in the United States, including the Eterna SCS platform and the Proclaim SCS family.

In August 2022, Merck announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH, a B. Braun subsidiary, to develop a neurostimulator device that can complement the existing drug therapies of patients with chronic inflammatory diseases.

Products Covered:

  • Closed-Loop Stimulation Systems
  • Deep Brain Stimulation (DBS)
  • Motor Cortex Stimulation (MCS)
  • Sacral Nerve Stimulation (SNS)
  • Spinal Cord Stimulation (SCS)
  • Trigeminal Nerve Stimulation (TNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Products

Device Types Covered:

  • Aneurysm Coiling & Embolization Devices
  • Cerebral balloon angioplasty & Stenting systems
  • Neurothrombectomy Devices

Disease Pathologies Covered:

  • Arteriovenous Malformations and Fistulas
  • Carotid Artery Stenosis
  • Cerebral Aneuryms
  • Ischemic Strokes
  • Other Diseases

Applications Covered:

  • Depression
  • Dystonia
  • Epilepsy
  • Gastroparesis
  • Pain Management
  • Parkinson's Disease
  • Tremors
  • Urinary and Fecal Incontinence
  • Other Applications

End Users Covered:

  • Hospitals
  • Cognitive Care Centers
  • Specialty Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurostimulation Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Closed-Loop Stimulation Systems
  • 5.3 Deep Brain Stimulation (DBS)
  • 5.4 Motor Cortex Stimulation (MCS)
  • 5.5 Sacral Nerve Stimulation (SNS)
  • 5.6 Spinal Cord Stimulation (SCS)
  • 5.7 Trigeminal Nerve Stimulation (TNS)
  • 5.8 Vagus Nerve Stimulation (VNS)
  • 5.9 Other Products

6 Global Neurostimulation Devices Market, By Device Type

  • 6.1 Introduction
  • 6.2 Aneurysm Coiling & Embolization Devices
    • 6.2.1 Embolic Coils
      • 6.2.1.1 Bare Detachable Coils
      • 6.2.1.2 Coated Detachable Coils
    • 6.2.2 Flow Diversion Devices
    • 6.2.3 Liquid Embolic Agents
  • 6.3 Cerebral balloon angioplasty & Stenting systems
    • 6.3.1 Balloon Catheters
    • 6.3.2 Carotid Artery Stents
  • 6.4 Neurothrombectomy Devices
    • 6.4.1 Clot Retrievals
    • 6.4.2 Suction & Aspiration Devices
    • 6.4.3 Snares
  • 6.5 Other Device Types

7 Global Neurostimulation Devices Market, By Disease Pathology

  • 7.1 Introduction
  • 7.2 Arteriovenous Malformations and Fistulas
  • 7.3 Carotid Artery Stenosis
  • 7.4 Cerebral Aneuryms
  • 7.5 Ischemic Strokes
  • 7.6 Other Diseases

8 Global Neurostimulation Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Depression
  • 8.3 Dystonia
  • 8.4 Epilepsy
  • 8.5 Gastroparesis
  • 8.6 Pain Management
  • 8.7 Parkinson's Disease
  • 8.8 Tremors
  • 8.9 Urinary and Fecal Incontinence
  • 8.10 Other Applications

9 Global Neurostimulation Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cognitive Care Centers
  • 9.4 Specialty Clinics
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Neurostimulation Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Axonics Modulation Technologies
  • 12.3 BioControl Medical
  • 12.4 Boston Scientific Corporation
  • 12.5 LivaNova
  • 12.6 Mainstay Medical
  • 12.7 Medtronic
  • 12.8 Merck & Co., Inc
  • 12.9 MicroTransponder
  • 12.10 Neuronetics
  • 12.11 NeuroPace
  • 12.12 Nevro Corp
  • 12.13 Nexeon MedSystems
  • 12.14 Saluda Medical
  • 12.15 Soterix Medical
  • 12.16 SPR Therapeutics
  • 12.17 Stimwave Technologies
  • 12.18 Synapse Biomedical
  • 12.19 Zynex Medical

List of Tables

  • Table 1 Global Neurostimulation Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurostimulation Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurostimulation Devices Market Outlook, By Closed-Loop Stimulation Systems (2021-2030) ($MN)
  • Table 4 Global Neurostimulation Devices Market Outlook, By Deep Brain Stimulation (DBS) (2021-2030) ($MN)
  • Table 5 Global Neurostimulation Devices Market Outlook, By Motor Cortex Stimulation (MCS) (2021-2030) ($MN)
  • Table 6 Global Neurostimulation Devices Market Outlook, By Sacral Nerve Stimulation (SNS) (2021-2030) ($MN)
  • Table 7 Global Neurostimulation Devices Market Outlook, By Spinal Cord Stimulation (SCS) (2021-2030) ($MN)
  • Table 8 Global Neurostimulation Devices Market Outlook, By Trigeminal Nerve Stimulation (TNS) (2021-2030) ($MN)
  • Table 9 Global Neurostimulation Devices Market Outlook, By Vagus Nerve Stimulation (VNS) (2021-2030) ($MN)
  • Table 10 Global Neurostimulation Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 11 Global Neurostimulation Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 12 Global Neurostimulation Devices Market Outlook, By Aneurysm Coiling & Embolization Devices (2021-2030) ($MN)
  • Table 13 Global Neurostimulation Devices Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 14 Global Neurostimulation Devices Market Outlook, By Bare Detachable Coils (2021-2030) ($MN)
  • Table 15 Global Neurostimulation Devices Market Outlook, By Coated Detachable Coils (2021-2030) ($MN)
  • Table 16 Global Neurostimulation Devices Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 17 Global Neurostimulation Devices Market Outlook, By Liquid Embolic Agents (2021-2030) ($MN)
  • Table 18 Global Neurostimulation Devices Market Outlook, By Cerebral balloon angioplasty & Stenting systems (2021-2030) ($MN)
  • Table 19 Global Neurostimulation Devices Market Outlook, By Balloon Catheters (2021-2030) ($MN)
  • Table 20 Global Neurostimulation Devices Market Outlook, By Carotid Artery Stents (2021-2030) ($MN)
  • Table 21 Global Neurostimulation Devices Market Outlook, By Neurothrombectomy Devices (2021-2030) ($MN)
  • Table 22 Global Neurostimulation Devices Market Outlook, By Clot Retrievals (2021-2030) ($MN)
  • Table 23 Global Neurostimulation Devices Market Outlook, By Suction & Aspiration Devices (2021-2030) ($MN)
  • Table 24 Global Neurostimulation Devices Market Outlook, By Snares (2021-2030) ($MN)
  • Table 25 Global Neurostimulation Devices Market Outlook, By Disease Pathology (2021-2030) ($MN)
  • Table 26 Global Neurostimulation Devices Market Outlook, By Arteriovenous Malformations and Fistulas (2021-2030) ($MN)
  • Table 27 Global Neurostimulation Devices Market Outlook, By Carotid Artery Stenosis (2021-2030) ($MN)
  • Table 28 Global Neurostimulation Devices Market Outlook, By Cerebral Aneuryms (2021-2030) ($MN)
  • Table 29 Global Neurostimulation Devices Market Outlook, By Ischemic Strokes (2021-2030) ($MN)
  • Table 30 Global Neurostimulation Devices Market Outlook, By Other Diseases (2021-2030) ($MN)
  • Table 31 Global Neurostimulation Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 Global Neurostimulation Devices Market Outlook, By Depression (2021-2030) ($MN)
  • Table 33 Global Neurostimulation Devices Market Outlook, By Dystonia (2021-2030) ($MN)
  • Table 34 Global Neurostimulation Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 35 Global Neurostimulation Devices Market Outlook, By Gastroparesis (2021-2030) ($MN)
  • Table 36 Global Neurostimulation Devices Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 37 Global Neurostimulation Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 38 Global Neurostimulation Devices Market Outlook, By Tremors (2021-2030) ($MN)
  • Table 39 Global Neurostimulation Devices Market Outlook, By Urinary and Fecal Incontinence (2021-2030) ($MN)
  • Table 40 Global Neurostimulation Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Global Neurostimulation Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 Global Neurostimulation Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 Global Neurostimulation Devices Market Outlook, By Cognitive Care Centers (2021-2030) ($MN)
  • Table 44 Global Neurostimulation Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 45 Global Neurostimulation Devices Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 46 Global Neurostimulation Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.